Результаты поиска

Гут Микробиота как ключевой модулятор хронических заболеваний: последствия для диабета, автономного иммунитета и рака.

Кишечная микробиота (ГМ) представляет собой сложную, динамичную и сложную экосистему. Она играет ключевую роль в области здравоохранения и болезней. ГМ взаимодействует с принимающей стороной и модифицирует различные физиологические функции, включая метаболизм, иммунное регулирование и неврологическую функцию. В настоящем описательном обзоре всесторонне анализируется роль ГМ в развитии и развитии three Основные хронические заболевания, а именно диабет, аутоиммунные расстройства и рак. Используя структурированную стратегию поиска литературы в таких базах данных, как Google Scientist, PubMed, Sco

Совпадение в аннотации оригинала
The gut microbiota (GM) represents an intricate, dynamic, and complex ecosystem. It plays a key role in health and disease. The GM interacts … ecreased microbial diversity. Similarly, in autoimmune disorders such as rheumatoid arthritis (RA), multiple sclerosis (MS), and inflammatory bowel disease (IBD), dysbiosis disrupts immune homeostasis, which in turn causes sustained inflammation and aberrant immune responses. Lastly, dysbiosis has been linked to the onset and progression of various gastrointestinal …

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.

Neuroinflammation plays a critical role in the onset and progression of many neurological disorders, including Multiple Sclerosis, Alzheimer's and Parkinson's diseases. In these clinical conditions the underlying neuroinflammatory processes are significantly heterogeneous. Nevertheless, a common link is the chronic activation of innate immune responses and imbalanced secretion of pro and anti-inflammatory mediators. In light of this, the discovery of robust biomarkers is crucial for screening, early diagnosis, and monitoring of neurological diseases. However, the difficulty to investigate bioc…

Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.

Multiple sclerosis (MS) is a chronic neurological disease characterized by inflammatory demyelination that disrupts neuronal transmission resulting in neurodegeneration progressive disability. While current treatments focus on immunosuppression to limit inflammation and further myelin loss, no approved therapies effectively promote remyelination to mitigate the progressive disability associated with chronic demyelination. Lysophosphatidic acid (LPA) is a pro-inflammatory lipid that is upregulated in MS patient plasma and cerebrospinal fluid (CSF). LPA activates the LPA1 receptor, resulting in …

[XVIII Митинг после ECTRIMS: Обзор новых разработок, представленных на Конгресс ECTRIMS 2025 (Часть I)]

18-е издание совещания Европейского комитета по лечению и исследованию множественной скlerоза (ECTRIMS) прошло 17-18 октября 2025 года в Мадриде, объединив испанских нейрологов, специализирующихся на множественной склерозе (МС), которые представили наиболее значимые достижения, обсуждённые на конгрессе ECTRIMS несколько дней ранее в Барселоне. Целью собрания было обобщить последние достижения в патогенезе, новые критерии диагностики и биомаркеры МС. Эта статья является первой частью двухчастной серии (I и II), которая обзором последних данных о транспортировке клеток в центральную нервную сист

Совпадение в аннотации оригинала
The 18th edition of the post-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting was held on 17-18 October 2025 in Madrid, bringing together Spanish neurologists specialising in multiple sclerosis (MS), who presented the most relevant advances discussed at the ECTRIMS congress held a few days earlier in Barcelona. The aim of…

Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis.

Multiple sclerosis (MS) is a chronic neurodegenerative disease marked by oligodendrocyte loss, which results in central neuronal demyelination. AC/cAMP/CREB signaling dysregulation is involved in the progression of MS, including mitochondrial dysfunctions, reduction in nerve growth factors, neuronal inflammation, apoptosis, and white matter degeneration. Our previous research has shown that Forskolin (FSK), a naturally occurring direct adenylyl cyclase (AC)/cAMP/CREB activator, has neuroprotective potential to alleviate pathogenic factors linked with numerous neurological abnormalities. The cu…

Роль вируса Эпштейн-Барр в патогенезе аутоиммунных заболеваний.

Справочная информация и цели: Вирус Эпштейн-Барр (ЭБВ) принадлежит семейству гамма-герпесвирусов. Данные из литературы говорят о том, что ЭБВ инициирует иммунную реакцию и производство антител. Хронические или повторяющиеся инфекции ЕБВ могут быть связаны с такими аутоиммунными заболеваниями, как системный волчан эритематос, синдром Шёгрена, ревматоидный артрит, множественный склероз или воспалительный кишечник. Цель этого обзора состоит в том, чтобы определить роль ОВБ в развитии и развитии аутоиммунных заболеваний. Материалы и методы: Был проведен поиск литературы с использованием PubMed, PM

Совпадение в аннотации оригинала
Background and Objectives: The Epstein-Barr virus (EBV) belongs to the gamma herpesviruses family. Evidence from the literature suggests tha … autoimmune diseases such as systemic lupus erythematosus, Sjögren's syndrome, rheumatoid arthritis, multiple sclerosis, or inflammatory bowel diseases. This review aims to establish the role of EBV in the development and progression of autoimmune diseases. Materials and Methods: A literature search was conducted using PubMed, PMC, Google Scholar, and SCOPUS. Relevan …

Насилие со стороны партнеров среди женщин с множественным склерозом.

AIM: Насилие со стороны партнера (IPV), которое широко распространено среди женщин с хроническими расстройствами, редко обсуждается и остается непризнанным, особенно среди пациентов с множественным склерозом (MS). Цель этого исследования состоит в том, чтобы оценить распространенность и характеристики ПМС среди женщин, страдающих ПМС. МЕТОДЫ: Это перекрестное исследование проводилось с января по июнь 2024 года среди замужних женщин, у которых был диагностирован множественный склероз (МС) в возрасте от 15 до 50 лет с минимальным сроком диагноза в один год в центре " Исфахан " . Опыт М

Совпадение в аннотации оригинала
AIM: Intimate partner violence (IPV), a highly prevalent issue in women with chronic disorders, is rarely discussed and remains unrecognized, especially among patients with Multiple Sclerosis (MS). The objective of this study is to assess the prevalence and characteristics of IPV among female patients with MS. METHODS: This cross-sectional study was conduct…

Ультрафиолетовое излучение и нейродегенерация: молекулярные механизмы, лежащие в основе двойного нейрозащитного и нейротоксичного воздействия.

Ультрафиолетовое излучение имеет сложную, зачастую противоречивую связь с риском/прогрессом нейродегенерации, охватывающую клинически диагностированные заболевания [Заболевания Паркинсона (PD), болезни Альцгеймера (AD), множественный склероз (MS) и амиотропический боковой склероз (ALS)] или промежуточные фенотипы (уменьшенный нейрогенесис, потеря гиппокампального объема). Цель этого обзора заключается в выявлении двойного воздействия УФ-излучения путем сбора и обобщения экспериментальных (доклинических и переводческих) данных, а также эпидемиологических данных. Нынешняя литература демонстрируе

Совпадение в аннотации оригинала
Ultraviolet radiation exhibits a complex, often contradictory link to neurodegeneration risk/progression, spanning clinically diagnosed diseases [Parkinson's Disease (PD), Alzheimer's Disease (AD), Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS)] or intermediate phenotypes (decreased neurogenesis, loss of hippocampal volume). The aim of this …

Neuronal somatic mutations are increased in multiple sclerosis lesions.

Neuroinflammation underpins neurodegeneration and clinical progression in multiple sclerosis (MS), but knowledge of processes linking these disease mechanisms remains incomplete. Here we investigated somatic single-nucleotide variants (sSNVs) in the genomes of 106 single neurons from post-mortem brain tissue of ten MS cases and 16 controls to determine whether somatic mutagenesis is involved. We observed an increase of 43.9 sSNVs per year in neurons from chronic MS lesions, a 2.5 times faster rate than in neurons from normal-appearing MS and control tissues. This difference was equivalent to 1…

Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions.

BACKGROUND AND OBJECTIVES: Slow-burning inflammation at the edge, and chronic demyelination at the core, of established multiple sclerosis (MS) lesions are potential mediators of disease progression. However, their relative contribution to progressive axonal damage has not been explored. Therefore, in this study, we investigated the comparative contribution of slow-burning inflammation and chronic demyelination to axonal attrition within MS lesions by measuring progressive tissue rarefaction. In addition, we use the visual system as a model to investigate the effect of chronic demyelination on…

Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation.

Multiple sclerosis (MS) is an incurable neurological illness that frequently causes chronic disability. Neurologists broach the diagnosis with dread. "I'll end up in a wheel chair" is the anguished cry of the newly diagnosed and mostly young patients. The past decade has improved our understanding of the immunopathogenesis of MS enormously. This has led to a plethora of clinical trials and the resultant emergence of several new drugs in various stages of development. In 1993, Food and Drug Administration (FDA) approved Betaseron for the treatment of MS. Todate, this is the only drug approved b…

Do cognitive dysfunction and fatigue impact illness perception in people living with multiple sclerosis?

Multiple sclerosis (MS) is a chronic disease with an unpredictable clinical course, presenting both recurrent relapses and progressive worsening over time. People living with MS (pwMS) are impacted physically, psychologically, and socially. Illness perception refers to a person's cognitive and emotional representations of their disease, which can impact their psychophysical well-being and treatment adherence.To assess the illness perception of pwMS and determine how it is impacted by cognitive dysfunction and fatigue.In this cross-sectional pilot survey study, the Brief Illness Perception Ques…

Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study.

Background: Multiple sclerosis (MS) is a chronic central nervous system disease, and primary progressive multiple sclerosis (PPMS) is one the main types of MS, which has unknown environmental risk factors. The present study was conducted with the aim to identify the association of waterpipe and cigarette smoking, substance abuse, and alcohol consumption with the risk of PPMS development. Methods: A population-based, case-control study was conducted in Tehran, Iran, on 146 PPMS cases and 294 controls. PPMS cases were diagnosed and confirmed by neurologists. Standard random digit dialing was use…

Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases.

Regulatory T-cells (Tregs) constitute a small subset of cells that are actively involved in maintaining self-tolerance, in immune homeostasis and in antitumor immunity. They are thought to play a significant role in the progression of cancer and are generally increased in patient with chronic lymphocytic leukemia (CLL). Their number correlates with more aggressive disease status and is predictive of the time to treatment, as well. Moreover, it is now clear that dysregulation in Tregs cell frequency and/or function may result in a plethora of autoimmune diseases, including multiple sclerosis, t…

Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia.

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) represents a public health problem worldwide. COVID-19 triggers a maladaptive cytokine release commonly referred to as cytokine storm syndrome with increased production of proinflammatory cytokines, which also appears to contribute to chronic neuroinflammation and neurodegenerative disorders' appearance, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. In this context, SARS-CoV-2 might enter the central nervous system through binding with the angiotensin converting enzyme 2 recept…

Correlation between decremental responses in repetitive nerve stimulation and disease progression rate in patients with amyotrophic lateral sclerosis.

OBJECTIVE: Decrement responses in repetitive nerve stimulation (RNS) are theoretically expected to correlate with the disease progression speed in amyotrophic lateral sclerosis (ALS). However, actual results have been controversial. We investigated this issue using ΔFS calculated from the ALS functional rating scale revised version (ALSFRS-R) and the duration of illness. METHODS: RNS results of the abductor pollicis brevis, trapezius, and deltoid muscles in our previous study were reviewed. We investigated correlations and multiple regressions regarding decremental percentage (Decr%), the amp

[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].

OBJECTIVE: The analysis of perinatal results in pregnant women with multiple sclerosis (MS) and the assessment of the influence of pregnancy on this chronic disease in the population of pregnant women in our hospital in the years 2003-2011. DESIGN: Retrospective analysis. SETTING: Department of Obstetrics and Gynecology and Department of Neurology, 2nd Faculty of Medicine, Charles University and the Motol Hospital, Prague. METHODS: Sixty-six women with the diagnosis of MS were included in our study in the years 2003-2011. All these women delivered at our clinic and were neurologically follo…

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.

Multiple sclerosis (MS) is a chronic, inflammatory disorder of the central nervous system (CNS) characterized by overlapping relapsing and progressive pathologies. Although they exist along a continuum, pathology in relapsing MS (RMS) is primarily driven by the peripheral adaptive immune system, while progressive MS (PMS) pathology is underpinned by innate immune activity and other pathologic processes compartmentalized within the CNS. While currently approved therapies are highly effective in targeting aspects underpinning relapsing pathology, they have limited efficacy in PMS due to either i…

Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.

BACKGROUND: Studies have shown positive effects of therapeutic exercise on motor- and cognitive function as well as on psychosocial outcomes in persons with multiple sclerosis (MS). A reduction of inflammatory stress through physical exercise has been suspected as one key mechanism, mediating the positive effects of exercise in the context of MS. The primary objective of this trial is to investigate the acute and chronic effects of different exercise modalities on (anti-)inflammatory immune signalling as well as on cognitive and functional capacity in persons with MS. METHODS: A two armed sin…

Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living.

OBJECTIVE: To evaluate the prevalence and impact of limb apraxia on manual dexterity and activities of daily living (ADLs) in patients with multiple sclerosis (MS). DESIGN: Survey. SETTING: University hospital. PARTICIPANTS: Consecutive patients (N=76) with clinically isolated syndrome, relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPMS) or primary progressive multiple sclerosis (PPMS), Expanded Disability Status Scale (EDSS) score from 0 to 6.5, and aged from 18 to 70 years were included. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Apr…